No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 16 | 20 | 4 | 22 | 21 | 4 | N/A | N/A |
| Operating profit | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | $m | -3 | -103 | -40 | -59 | -4 | -47 | N/A | N/A |
| EPS reported | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | Locked | Locked | Locked |
| Environmental score | Locked | Locked | Locked |
| Social score | Locked | Locked | Locked |
| Governance score | Locked | Locked | Locked |
| Risk rating | Locked | Locked | Locked |
Company overview
Alset Inc., established in 2018 and based in Bethesda, Maryland, is a diversified enterprise with a primary focus on real estate development. The company, which adopted its current name in October 2022, having previously been known as Alset EHome International Inc., operates through multiple distinct business divisions. Its Real Estate segment undertakes property development initiatives, including land subdivision and residential rental projects, and also collaborates on third-party developments. This division's activities span a broad international footprint, encompassing the United States, Singapore, Hong Kong, Australia, South Korea, and the People's Republic of China. The Digital Transformation Technology segment provides comprehensive services ranging from support and implementation to development, utilizing cutting-edge technologies such as blockchain, e-commerce platforms, social media tools, AI-driven customer service applications, and metaverse solutions. This segment primarily concentrates on business-to-business (B2B) offerings, including instant messaging and workflow systems, integrated e-commerce and payment solutions, direct marketing platforms, digital real estate services, and crucial brand protection measures like counterfeit and fraud detection. Moreover, it delivers mobile application development and broader IT services to a diverse client base, including end-users, service providers, and commercial entities across various platforms. Through its Biohealth segment, Alset engages in the entire lifecycle of biohealth products and services, from initial research and development to testing, manufacturing, licensing, and distribution. These offerings reach consumers via a variety of channels, including traditional retail outlets, direct sales, network marketing, and e-commerce. Finally, the Other Business Activities segment encompasses a wide array of services. These include strategic corporate advisory and business development consultation, the operation of food and beverage establishments such as cafes and restaurants, asset management, corporate restructuring, and leveraged buy-out services. This segment also oversees a portfolio of trading securities and is active in both consumer products and financial services.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Alset Inc., established in 2018 and based in Bethesda, Maryland, is a diversified enterprise with a primary focus on real estate development. The company, which adopted its current name in October 2022, having previously been known as Alset EHome International Inc., operates through multiple distinct business divisions. Its Real Estate segment undertakes property development initiatives, including land subdivision and residential rental projects, and also collaborates on third-party developments. This division's activities span a broad international footprint, encompassing the United States, Singapore, Hong Kong, Australia, South Korea, and the People's Republic of China. The Digital Transformation Technology segment provides comprehensive services ranging from support and implementation to development, utilizing cutting-edge technologies such as blockchain, e-commerce platforms, social media tools, AI-driven customer service applications, and metaverse solutions. This segment primarily concentrates on business-to-business (B2B) offerings, including instant messaging and workflow systems, integrated e-commerce and payment solutions, direct marketing platforms, digital real estate services, and crucial brand protection measures like counterfeit and fraud detection. Moreover, it delivers mobile application development and broader IT services to a diverse client base, including end-users, service providers, and commercial entities across various platforms. Through its Biohealth segment, Alset engages in the entire lifecycle of biohealth products and services, from initial research and development to testing, manufacturing, licensing, and distribution. These offerings reach consumers via a variety of channels, including traditional retail outlets, direct sales, network marketing, and e-commerce. Finally, the Other Business Activities segment encompasses a wide array of services. These include strategic corporate advisory and business development consultation, the operation of food and beverage establishments such as cafes and restaurants, asset management, corporate restructuring, and leveraged buy-out services. This segment also oversees a portfolio of trading securities and is active in both consumer products and financial services.